Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety Study of Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered With Other Pediatric Vaccines to Healthy Toddlers

Next Previous
X
Search
Trial Profile

Safety Study of Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered With Other Pediatric Vaccines to Healthy Toddlers

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 May 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Hepatitis A vaccine inactivated; Measles mumps and rubella virus vaccine; MMR-varicella zoster virus vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate; Varicella zoster virus vaccine live
  • Indications Hepatitis A; Measles; Meningococcal infections; Mumps; Rubella
  • Focus Adverse reactions; Registrational
  • Sponsors Sanofi Pasteur

    • Most Recent Events

    • 08 Nov 2012 Pivotal clinical trial data has been published in the Pediatric Infectious Disease Journal, according to a Sanofi Pasteur media release.
    • 01 Nov 2012 Results published in the Pediatric Infectious Disease Journal.
    • 22 Apr 2011 Based in part on the results from this trial, the US FDA approved Menactra for use in infants aged 9-23 months of age, for the prevention of invasive meningococcal disease caused by serogroups A, C, Y and W-135.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top